Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy
Randomized, Controlled Trial of Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy.
1 other identifier
interventional
115
1 country
1
Brief Summary
Purpose of this study is to investigate the pain outcomes and satisfaction of pain relief for pediatric patients receiving needleless jet-injected (J-Tip) lidocaine prior to regional anesthesia with femoral and/or sciatic nerve block and general anesthesia for arthroscopic knee surgery compared to femoral nerve block and/or sciatic nerve block with needle injected lidocaine prior to regional and general anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2015
CompletedFirst Submitted
Initial submission to the registry
December 13, 2015
CompletedFirst Posted
Study publicly available on registry
January 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2019
CompletedResults Posted
Study results publicly available
April 28, 2020
CompletedMay 5, 2020
April 1, 2020
4 years
December 13, 2015
March 3, 2020
April 27, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Baseline Pain Assessment Before Knee Arthroscopy Via the Visual Analog Scale.
Pain will be assessed via the Visual Analog Scale by the patient before administration of the nerve block. Patient will report on a scale of 0 to 10 what their perceived pain is. 0 is no pain with 10 being worst pain patient ever experienced.
During Baseline Assessment, Taking Approximately 20 Minutes, Before Nerve Block
Pain Assessment After Knee Arthroscopy Via the Visual Analog Scale
Pain will be assess via the Visual Analog Scale by the patient after the knee arthroscopy though first post op office visit and average of one week. Patient will report on a scale of 0 to 10 what their perceived pain is. 0 is no pain with 10 being worst pain patient ever experienced.
During Follow-up Assessment at an Average of 1 Week Post Op
Secondary Outcomes (1)
Satisfaction Via a 0 to 10 Rating Scale at Follow up
At the follow up appointment, an average of one week after the procedure.
Study Arms (2)
Group A
EXPERIMENTALParticipants in Group A will receive 0.25 mL of 1% plain lidocaine delivered by the J-tip injector at the regional block site prior to introduction of the needle for the nerve block procedure.
Group B
ACTIVE COMPARATORParticipants in Group B will receive 2 mL of 1% plain lidocaine injected by syringe and 25 gauge needle at the regional block site prior to introduction of the needle for the nerve block procedure.
Interventions
After sterile preparation, the J-tip injector will be placed on the skin at the selected site of the regional block needle introduction. Firm pressure will be placed with the J-tip injector on the site for the chosen block, the safety ring slid down, the trigger pressed and the tip held firmly on the skin for three seconds. One quarter of a milliliter of one percent lidocaine will be injected with the characteristic "pop" and "hissing" sounds inherent to the J-tip injector.
The same initial timeout and sterile prep procedure will be followed for the use of local syringe and 25 gauge needle injection of 1% lidocaine ninety seconds prior to introduction of the regional block needle.
Eligibility Criteria
You may qualify if:
- Subjects between the ages of eleven and seventeen undergoing arthroscopic knee surgery.
- Able to independently complete the Visual Analog pain scales.
- Subjects who are neurologically intact at area of injection.
- English speaking.
You may not qualify if:
- Subjects with known allergies to lidocaine.
- Presence of developmental delay.
- Subjects with blood disorders affecting coagulation.
- Subjects on blood thinners.
- Subjects receiving chemotherapeutic agents.
- Those who use or receive analgesia prior to procedure, except for acetaminophen or Non-steroidal anti-inflammatory medications.
- Any other local sedation at the area of nerve block injection.
- Non-English Speaking
- Subjects with signs of skin infection or pathology at the injection site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orlando Health
Orlando, Florida, 32806, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Daryl C. Osbahr, MD
- Organization
- Orlando Health
Study Officials
- PRINCIPAL INVESTIGATOR
Daryl C Osbahr, MD
Orlando Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sports Medicine Orthopaedic physician
Study Record Dates
First Submitted
December 13, 2015
First Posted
January 7, 2016
Study Start
September 3, 2015
Primary Completion
August 28, 2019
Study Completion
August 28, 2019
Last Updated
May 5, 2020
Results First Posted
April 28, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share